POU5F1 and prostate carcinoma: In prostate cancer, OCT4′s influence extends beyond cancer stem cell maintenance: its overexpression has been associated with increased tumor aggressiveness, enhanced metastatic potential, and resistance to both ADT and chemotherapy [21,22].